Krka, d. d.
KRK
Rang in aandelen
#2136
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Aandeelprijs
$313.05
Marktkapitalisatie
$9.48B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
27.14%
Land
SI
Handel Krka, d. d. (KRK)
Categorie
Healthcare
Winst voor Krka, d. d. (KRK)
Winst in Jun 2026 TTM: $613.56M
Volgens de meest recente financiële verslagen van Krka, d. d. bedraagt de huidige winst van het bedrijf $613.56M. In 2023 behaalde het bedrijf een winst van $405.84M, een daling ten opzichte van de winst van 2022, die $464.55M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Krka, d. d. van 2010 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $613.56M | 40.70% |
| 2024 | $436.08M | 7.45% |
| 2023 | $405.84M | -12.64% |
| 2022 | $464.55M | 12.72% |
| 2021 | $412.12M | -0.18% |
| 2020 | $412.85M | 29.40% |
| 2019 | $319.06M | 37.06% |
| 2018 | $232.79M | 10.12% |
| 2017 | $211.39M | 72.75% |
| 2016 | $122.37M | -37.64% |
| 2015 | $196.22M | -7.49% |
| 2014 | $212.12M | -23.39% |
| 2013 | $276.88M | 10.18% |
| 2012 | $251.29M | -2.93% |
| 2011 | $258.87M | -8.40% |
| 2010 | $282.60M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 187.59% |
IN
|
